Alok Tayi, Ph.D.
Why Seamless Submissions and Good Compliance Envelopes Matter
April 22, 2020
Are you finding it increasingly challenging to manage your organization’s regulatory submission process? The entire process of developing a drug from preclinical research to marketing takes...
Replace GxP SFTP/File Servers with Modern Solutions
December 12, 2019
Data is the lifeblood of the life sciences. As therapeutics, medical devices, and diagnostics advance from early-stage development into clinical testing and beyond, the scrutiny of reported data and...
3 Ways to Mitigate Data Manipulation Risk in Drug Development
August 15, 2019
Developing new drugs is an expensive, time-consuming endeavor. A critical output of the drug development process, besides the compound itself, is data. As you may have read recently...
